• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经状态对子宫内膜癌患者的总生存期有影响。

Menopausal Status Contributes to Overall Survival in Endometrial Cancer Patients.

作者信息

Barczyński Bartłomiej, Frąszczak Karolina, Wnorowski Artur, Kotarski Jan

机构信息

1st Chair and Department of Oncological Gynaecology and Gynaecology, Medical University in Lublin, 20-081 Lublin, Poland.

Department of Biopharmacy, Medical University in Lublin, 20-081 Lublin, Poland.

出版信息

Cancers (Basel). 2023 Jan 10;15(2):451. doi: 10.3390/cancers15020451.

DOI:10.3390/cancers15020451
PMID:36672399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9856958/
Abstract

Endometrial cancer is the most common female genital tract malignancy in developed countries that occurs predominantly in postmenopausal women. The primary objective of our research was to investigate whether menopause status together with selected conventional prognostic indicators may contribute to overall (all-cause) survival in endometrial cancer patients. For this purpose, we applied the Cox proportional hazards regression model. Patients in advanced FIGO stage showed a relatively poor survival rate. The time since last menstruation and postoperative FSH concentration were identified as unfavorable prognostic factors in our model. Additionally, age at diagnosis, BMI value, adjuvant treatment (brachytherapy), and parity showed no impact on survival. To our knowledge, this is the first study to report a prognostic model for endometrial cancer including exact time from last menstruation as one of the prognostic variables. Due to the fact that there are no stratifying systems to reliably predict survival in patients with endometrial cancer, there is a strong need to revise and update existing models using complementary prognostic indicators. Collection of precise data on various risk factors may contribute to increased accuracy of artificial intelligence algorithms in order to personalize cancer care in the near future.

摘要

子宫内膜癌是发达国家最常见的女性生殖道恶性肿瘤,主要发生在绝经后女性中。我们研究的主要目的是调查绝经状态以及选定的传统预后指标是否有助于子宫内膜癌患者的总(全因)生存率。为此,我们应用了Cox比例风险回归模型。国际妇产科联盟(FIGO)晚期患者的生存率相对较低。末次月经时间和术后促卵泡生成素(FSH)浓度在我们的模型中被确定为不良预后因素。此外,诊断时年龄、体重指数(BMI)值、辅助治疗(近距离放疗)和产次对生存率没有影响。据我们所知,这是第一项将末次月经的确切时间作为预后变量之一来报告子宫内膜癌预后模型的研究。由于目前没有可靠预测子宫内膜癌患者生存率的分层系统,因此迫切需要使用补充性预后指标来修订和更新现有模型。收集各种风险因素的精确数据可能有助于提高人工智能算法的准确性,以便在不久的将来实现癌症护理的个性化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/e271f307af0a/cancers-15-00451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/797011fdb34f/cancers-15-00451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/687ebe95e414/cancers-15-00451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/e271f307af0a/cancers-15-00451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/797011fdb34f/cancers-15-00451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/687ebe95e414/cancers-15-00451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/493d/9856958/e271f307af0a/cancers-15-00451-g003.jpg

相似文献

1
Menopausal Status Contributes to Overall Survival in Endometrial Cancer Patients.绝经状态对子宫内膜癌患者的总生存期有影响。
Cancers (Basel). 2023 Jan 10;15(2):451. doi: 10.3390/cancers15020451.
2
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.淋巴管间隙浸润和主动脉旁阳性淋巴结组数量可预测子宫内膜癌淋巴结阳性患者的生存率。
Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026.
3
The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.年龄对接受术后放疗的子宫内膜癌患者长期预后的影响。
Gynecol Oncol. 2006 Oct;103(1):87-93. doi: 10.1016/j.ygyno.2006.01.038. Epub 2006 Mar 20.
4
Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes.未分化子宫内膜癌:一项基于国家癌症数据库的预后因素及治疗结果分析
Int J Gynecol Cancer. 2019 Sep;29(7):1126-1133. doi: 10.1136/ijgc-2019-000465. Epub 2019 Aug 17.
5
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.盆腔淋巴结计数是国际妇产科联盟(FIGO)I期和II期具有高危组织学特征的子宫内膜癌的一个重要预后变量。
Gynecol Oncol. 2006 Jul;102(1):92-7. doi: 10.1016/j.ygyno.2005.11.032. Epub 2006 Jan 10.
6
Poorer survival of nulliparous women with endometrial carcinoma.
Cancer. 1998 Apr 1;82(7):1328-33. doi: 10.1002/(sici)1097-0142(19980401)82:7<1328::aid-cncr16>3.0.co;2-8.
7
The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.手术、肿瘤大小、恶性程度、绝经状态及DNA倍体在子宫内膜间质肉瘤中的预后意义。
Gynecol Oncol. 1996 Aug;62(2):254-9. doi: 10.1006/gyno.1996.0224.
8
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.术后全身免疫炎症指数(SII):子宫内膜癌的一个优越预后因素。
Front Surg. 2021 Oct 22;8:704235. doi: 10.3389/fsurg.2021.704235. eCollection 2021.
9
Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.以流式细胞术检测的S期分数衡量的细胞增殖,是国际妇产科联盟(FIGO)I期子宫内膜样腺癌的一个强有力的预后指标:一项基于人群的研究。
Acta Obstet Gynecol Scand. 2015 Oct;94(10):1064-73. doi: 10.1111/aogs.12704. Epub 2015 Jul 27.
10
Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.ABO 血型是否为子宫内膜样子宫内膜癌患者的风险或预后因素?德国的一项回顾性分析。
Blood Transfus. 2020 Nov;18(6):465-470. doi: 10.2450/2020.002-20. Epub 2020 Jun 4.

引用本文的文献

1
A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer.林奇综合征简要回顾:理解子宫内膜癌和结直肠癌的双重癌症风险
Oncol Rev. 2025 May 16;19:1549416. doi: 10.3389/or.2025.1549416. eCollection 2025.

本文引用的文献

1
An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study.一种基于人工智能的癌症患者数据分析与预后评估工具:Clarify研究结果
Cancers (Basel). 2022 Aug 22;14(16):4041. doi: 10.3390/cancers14164041.
2
Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome.绝经前女性和年轻女性的子宫内膜癌:危险因素和结局。
Int J Environ Res Public Health. 2022 Jul 25;19(15):9059. doi: 10.3390/ijerph19159059.
3
Risk Factors and Prognosis of Early Recurrence in Stage I-II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study.
Ⅰ-Ⅱ期子宫内膜癌早期复发的危险因素及预后:一项大规模、多中心回顾性研究
Front Med (Lausanne). 2022 Apr 14;9:808037. doi: 10.3389/fmed.2022.808037. eCollection 2022.
4
Preoperative detection of occult endometrial malignancies in endometrial hyperplasia to improve primary surgical therapy: A scoping review of the literature.术前检测子宫内膜增生中的隐匿性子宫内膜恶性肿瘤,以改善原发性手术治疗:文献范围综述。
Int J Gynaecol Obstet. 2022 Oct;159(1):21-42. doi: 10.1002/ijgo.14139. Epub 2022 Mar 3.
5
Development and Validation of a Novel Prognostic Model for Endometrial Cancer Based on Clinical Characteristics.基于临床特征的子宫内膜癌新型预后模型的开发与验证
Cancer Manag Res. 2021 Nov 27;13:8879-8886. doi: 10.2147/CMAR.S338861. eCollection 2021.
6
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.术后全身免疫炎症指数(SII):子宫内膜癌的一个优越预后因素。
Front Surg. 2021 Oct 22;8:704235. doi: 10.3389/fsurg.2021.704235. eCollection 2021.
7
Identification of risk factors for the prognosis of Chinese patients with endometrial carcinoma.识别中国子宫内膜癌患者预后的风险因素。
Medicine (Baltimore). 2021 Sep 24;100(38):e27305. doi: 10.1097/MD.0000000000027305.
8
Symptomatic menopause: Additional challenges for incarcerated women.有症状的绝经期:监禁女性的额外挑战。
Maturitas. 2021 Aug;150:37-41. doi: 10.1016/j.maturitas.2021.05.009. Epub 2021 May 31.
9
Predictors of endometrial carcinoma in patients with atypical endometrial hyperplasia at a tertiary gynaecological cancer centre in Western Australia.西澳大利亚州一家三级妇科癌症中心中,非典型性子宫内膜增生患者中子宫内膜癌的预测因素。
Aust N Z J Obstet Gynaecol. 2021 Apr;61(2):275-283. doi: 10.1111/ajo.13300. Epub 2021 Jan 6.
10
Clinical factors as prognostic variables among molecular subgroups of endometrial cancer.子宫内膜癌分子亚群中临床因素的预后变量。
PLoS One. 2020 Nov 24;15(11):e0242733. doi: 10.1371/journal.pone.0242733. eCollection 2020.